找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cell Penetrating Peptides; Methods and Protocol ülo Langel Book 2022Latest edition The Editor(s) (if applicable) and The Author(s), under e

[復(fù)制鏈接]
樓主: 小巷
51#
發(fā)表于 2025-3-30 08:16:13 | 只看該作者
52#
發(fā)表于 2025-3-30 15:05:31 | 只看該作者
53#
發(fā)表于 2025-3-30 20:24:54 | 只看該作者
In Silico Design of Chemically Modified Cell-Penetrating Peptidesng drug delivery vehicles. Numerous in silico tools have been developed over the years to design and predict the cell-penetrating peptides that contain natural amino acids. The majority of natural cell-penetrating peptides have several limitations including stability, immunogenicity as well as got e
54#
發(fā)表于 2025-3-30 21:46:32 | 只看該作者
55#
發(fā)表于 2025-3-31 04:51:26 | 只看該作者
A Native CPP from Rattlesnake with Therapeutic and Theranostic Propertiestides can rely on a high content of positive charges, as it is the case of the native CPP crotamine. Crotamine is a polypeptide of about 42 amino acid residues with high content of basic residues as Arg and Lys. Although most of known CPPs are linear peptides,?native crotamine from the venom of a So
56#
發(fā)表于 2025-3-31 08:54:56 | 只看該作者
57#
發(fā)表于 2025-3-31 09:42:27 | 只看該作者
Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology EVs are able to transfer their contents (including nucleic acids, proteins, lipids, and small molecules) to recipient cells, and thus hold great promise as drug delivery vehicles. However, their therapeutic application is limited by lack of efficient cargo loading strategies, a need to improve EV t
58#
發(fā)表于 2025-3-31 15:10:04 | 只看該作者
59#
發(fā)表于 2025-3-31 17:48:26 | 只看該作者
Membrane Molecular Interactions and Induced Structures of CPPsal properties, they are classified as three main groups, namely hydrophobic, amphipathic, and hydrophilic. They are capable of interacting with the cell membrane without inducing serious toxicity, and they can carry cargo molecules across the membrane. Cargo molecules could be different therapeutics
60#
發(fā)表于 2025-4-1 00:23:05 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-29 09:44
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
徐州市| 静海县| 琼结县| 扶余县| 城步| 恩平市| 宜州市| 湖州市| 玛沁县| 南部县| 武平县| 都江堰市| 兴业县| 昂仁县| 宁远县| 化隆| 绥中县| 安化县| 沿河| 诸城市| 湛江市| 长寿区| 南通市| 海口市| 迭部县| 临猗县| 四子王旗| 颍上县| 莱芜市| 丹东市| 徐汇区| 同江市| 文登市| 姜堰市| 龙江县| 常山县| 鄂托克前旗| 津市市| 金川县| 腾冲县| 巴塘县|